Ovarian Neoplasms clinical trials

Explore recruiting ovarian neoplasms clinical trials.

Recruiting ovarian neoplasms studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Ovarian Neoplasms trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Clinical Activity of GSK5733584 for Injection in Subjects with Advanced Solid Tumors

France, Sweden, Italy, Belgium, Spain, Finland +2 more

Phase I and Phase II (Integrated)- Other EU CTIS Study details

OPAL Master Protocol: A Phase 1B/2 Multicohort Umbrella Study to Evaluate the Safety and Efficacy of Novel Treatments and/or Combinations of Treatments in Participants with Ovarian Cancer (OPAL) (PR-3000-02-005/213357) Cohort C: Open-label Phase 2, Randomized, Controlled Multicenter Study Comparing Niraparib Versus Platinum-Taxane Doublet Chemotherapy as Neoadjuvant Treatment in Participants with Homologous Recombination- Deficient Stage III/IV Ovarian Cancer

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

J5E-MC-JZXB - FRAmework-01: A Two-Part Phase 3 Study of Sofetabart Mipitecan (LY4170156) versus Chemotherapy or Mirvetuximab Soravtansine in Platinum-Resistant Ovarian Cancer, and Sofetabart Mipitecan plus Bevacizumab versus Platinum-Based Chemotherapy plus Bevacizumab in Platinum-Sensitive Ovarian Cancer

Netherlands, Hungary, France, Austria, Poland, Italy +9 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

C5731005 _ A Phase 2 Basket Study of Disitamab Vedotin in Adult Subjects with Previously Treated, Locally-Advanced Unresectable or Metastatic Solid Tumors That Express HER2

Italy, France, Germany, Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors (FiREBOLT)

Germany, Netherlands

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Ovarian Neoplasms trials by city

Ovarian Neoplasms in Toronto Ovarian Neoplasms in Vancouver Ovarian Neoplasms in Montreal Ovarian Neoplasms in Calgary Ovarian Neoplasms in Edmonton Ovarian Neoplasms in Ottawa Ovarian Neoplasms in Winnipeg Ovarian Neoplasms in Quebec City Ovarian Neoplasms in Hamilton Ovarian Neoplasms in Kitchener Ovarian Neoplasms in London Ovarian Neoplasms in Halifax Ovarian Neoplasms in New York Ovarian Neoplasms in Los Angeles Ovarian Neoplasms in Chicago Ovarian Neoplasms in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease